These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 8710158

  • 1. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 2. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?
    Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH.
    Nephrol Dial Transplant; 1996 Mar; 11(3):492-7. PubMed ID: 8671820
    [Abstract] [Full Text] [Related]

  • 3. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M, Walter H, Thies K, Anders C, Stein M, Hellstern P, Brass H.
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [Abstract] [Full Text] [Related]

  • 4. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J, Ostrowski G, Niemczyk S, Przedlacki J, Wardyn K, Puka J, Włodarczyk D, Switalski M, Zakrzewska T, Ostrowski K.
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [Abstract] [Full Text] [Related]

  • 5. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.
    Fishbane S, Lynn RI.
    Am J Kidney Dis; 1995 Mar; 25(3):426-32. PubMed ID: 7872320
    [Abstract] [Full Text] [Related]

  • 6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [Abstract] [Full Text] [Related]

  • 7. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC.
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [Abstract] [Full Text] [Related]

  • 8. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency.
    Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labb RF.
    Pediatrics; 1999 Sep; 104(3):e37. PubMed ID: 10469820
    [Abstract] [Full Text] [Related]

  • 9. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
    Matzkies FK, Cullen P, Schaefer L, Hartmann M, Hohage H, Schaefer RM.
    South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
    [Abstract] [Full Text] [Related]

  • 10. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH.
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [Abstract] [Full Text] [Related]

  • 11. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC, Tsai TJ, Chen YM, Lin SL, Hsieh BS.
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [Abstract] [Full Text] [Related]

  • 12. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [Abstract] [Full Text] [Related]

  • 13. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 14. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 15. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.
    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G.
    Nephrol Dial Transplant; 2001 Jul 03; 16(7):1416-23. PubMed ID: 11427634
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
    Kim JM, Ihm CH, Kim HJ.
    Int J Lab Hematol; 2008 Feb 03; 30(1):46-52. PubMed ID: 18190467
    [Abstract] [Full Text] [Related]

  • 17. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan 03; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 18. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y.
    Nephrol Dial Transplant; 2007 Apr 03; 22(4):1156-62. PubMed ID: 17237481
    [Abstract] [Full Text] [Related]

  • 19. Central role of zinc protoporphyrin in staging iron deficiency.
    Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R.
    Clin Chem; 1994 May 03; 40(5):768-73. PubMed ID: 8174250
    [Abstract] [Full Text] [Related]

  • 20. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
    Tsuchiya K, Okano H, Teramura M, Iwamoto Y, Yamashita N, Suda A, Shimada K, Nihei H, Ando M.
    Clin Nephrol; 2003 Feb 03; 59(2):115-23. PubMed ID: 12608554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.